Contemporaneous Measurement of Outer and Inner Membrane Permeability in Gram-negative Bacteria.
Antimicrobial peptides
Gram-negative bacteria
N-phenyl-1-naphthylamine
Outer and inner membrane permeability
Propidium iodide
Journal
Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102
Informations de publication
Date de publication:
05 Mar 2020
05 Mar 2020
Historique:
received:
07
11
2019
revised:
15
01
2020
accepted:
17
01
2020
pmc-release:
05
03
2021
entrez:
4
3
2021
pubmed:
5
3
2021
medline:
5
3
2021
Statut:
epublish
Résumé
The emergence and rapid spread of multidrug resistance in bacteria have led to the urgent need for novel antibacterial agents. Membrane permeabilization is the mechanism for many antibacterial molecules that are being developed against gram-negative bacteria. Thus, to determine the efficacy of a potential antibacterial molecule, it is important to assess the change in bacterial membrane permeability after treatment. This study describes the protocol for the assays of outer and inner membrane permeability using the fluorescent probes N-phenyl-1-naphthylamine and propidium iodide. Compared with other experiments, such as electron microscopy and the assay of minimal bactericidal concentration, this methodology provides a simpler, faster, and cost-effective way of estimating the membrane-permeabilizing effect and bactericidal efficacy of antibacterial molecules. This study presents an optimized protocol with respect to the classical protocols by incubating bacteria with antibacterial molecules in the culture condition identical to that of antibacterial assays and then detecting the signal of the fluorescent probe in the buffer without broth and antibacterial molecules. This protocol avoids the effect of nutrient deficiency on the physiological status of bacteria and the interference of antibacterial molecules towards the fluorescent probe. Thus, this method can effectively and precisely evaluate the membrane permeability and match the results obtained from other antibacterial assays, such as minimum inhibitory concentration and time-kill curve assays.
Identifiants
pubmed: 33659522
doi: 10.21769/BioProtoc.3548
pii: e3548
pmc: PMC7842588
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e3548Informations de copyright
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare no conflict of interest.
Références
Biomaterials. 2016 May;87:32-45
pubmed: 26897538
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-5
pubmed: 8577744
ACS Infect Dis. 2016 Feb 12;2(2):132-9
pubmed: 27624964
Nat Commun. 2019 Aug 6;10(1):3517
pubmed: 31388008
Infect Drug Resist. 2019 May 27;12:1393-1405
pubmed: 31239720
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4283-9
pubmed: 27161645